Shree Ram Proteins Limited carries a market capitalization of 149.94M, placing it among publicly traded companies globally. Its enterprise value stands at 600.98M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 149.94M |
| Enterprise Value | 600.98M |
Shree Ram Proteins Limited currently has 214.20M shares outstanding.
| Shares Outstanding | 214.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Shree Ram Proteins Limited trades at a trailing price-to-earnings ratio of 17.04. The price-to-sales ratio is 1.57, and the price-to-book ratio stands at 1.09.
| PE Ratio | 17.04 |
| PS Ratio | 1.57 |
| PB Ratio | 1.09 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Shree Ram Proteins Limited trades at an EV/EBITDA multiple of 26.85 and an EV/FCF ratio of 44.43. The EV/Sales ratio of 4.07 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 26.85 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.07 |
| EV / EBITDA | 26.85 |
| EV / EBIT | 26.85 |
| EV / FCF | 44.43 |
Shree Ram Proteins Limited maintains a current ratio of 2.22, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 79.46, indicating elevated leverage, while an interest coverage ratio of -6.33 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.22 |
| Quick Ratio | 0.00 |
| Debt / Equity | 79.46 |
| Debt / EBITDA | -4.09 |
| Interest Coverage | -6.33 |
| Return on Equity (ROE) | -29.95 |
| Return on Assets (ROA) | -9.38 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.52 |
Over the trailing twelve months, Shree Ram Proteins Limited has paid -5.29M in income taxes, reflecting an effective tax rate of 27.81.
| Income Tax | -5.29M |
| Effective Tax Rate | 27.81 |
Shree Ram Proteins Limited's stock has declined approximately -41.66667% over the past 52 weeks. The 50-day moving average sits at 0.41, while the 200-day moving average is 0.56.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.66667% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 0.56 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Shree Ram Proteins Limited generated 147.66M in revenue and converted that into -95.85M in net income, yielding earnings per share of -0.45. EBITDA reached -90.29M, while operating income came in at -90.29M.
| Revenue | 147.66M |
| Gross Profit | -45.57M |
| Operating Income | -90.29M |
| Pretax Income | -101.14M |
| Net Income | -95.85M |
| EBITDA | -90.29M |
| EBIT | -90.29M |
| Earnings Per Share (EPS) | -0.45 |
Shree Ram Proteins Limited holds 970,000.00 in cash and equivalents against 369.40M in total debt, resulting in a net debt position of 368.43M. Total book value stands at 214.20M, with working capital of 506.33M providing operational flexibility.
| Cash & Cash Equivalents | 970,000.00 |
| Total Debt | 369.40M |
| Net Debt | 368.43M |
| Equity (Book Value) | 214.20M |
| Book Value Per Share | 1.01 |
| Working Capital | 506.33M |
Shree Ram Proteins Limited operates with a gross margin of -30.86, reflecting its pricing power and cost economics. The operating margin of -61.15 and net profit margin of -64.91 provide insight into operational efficiency.
| Gross Margin | -30.86 |
| Operating Margin | -61.15 |
| Pretax Margin | -68.49 |
| Profit Margin | -64.91 |
| EBITDA Margin | -61.15 |
Shree Ram Proteins Limited's most recent stock split took place on July 6, 2023 with a 5:6 split ratio.
| Last Split Date | 7/6/2023 |
| Split Ratio | 5:6 |
Shree Ram Proteins Limited posts an Altman Z-Score of 0.73, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.73 |